Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.55 | N/A |
| PEG Ratio (TTM) | -6.71 | N/A |
| P/S Ratio (TTM) | 1.00 | N/A |
| P/B Ratio (TTM) | 1.54 | N/A |
| P/FCF Ratio (TTM) | 14.97 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.26 | N/A |
| Price to 5YR AVG FCF Ratio | 23.61 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.21% | N/A |
| ROE (TTM) | 9.05% | N/A |
| Net Profit Margin (TTM) | 5.68% | N/A |
| ROIC 5YR AVG | 16.44% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 9.14% | 87.64% | 45.62% |
| Revenue | 2.13% | 13.35% | 9.46% |
| Net Income | 8.89% | 88.33% | 46.22% |
| Cash Flow | 12.38% | 22.39% | 16.15% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.06 | N/A |
| Quick Ratio (TTM) | 1.84 | N/A |
| D/E Ratio (TTM) | 0.26 | N/A |
| Interest Coverage (TTM) | 7.30 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 3.27 | N/A |
| LTL to 5YR AVG FCF | 4.15 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.52% | N/A |